# Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent Preterm Birth

> **NCT00131235** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **Tampere University** · enrollment: 1320 (actual)

## Conditions studied

- Malaria
- Sexually Transmitted Diseases
- Preterm Birth
- Pregnancy

## Interventions

- **DRUG:** Sulfadoxine-pyrimethamine treatment twice during pregnancy
- **DRUG:** Sulfadoxine-pyrimethamine at 4-week intervals
- **DRUG:** Sulfadoxine-pyrimethamine every 4 weeks + azithromycin twice

## Key facts

- **NCT ID:** NCT00131235
- **Lead sponsor:** Tampere University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2003-12
- **Primary completion:** 2007-06
- **Final completion:** 2027-12-31
- **Target enrollment:** 1320 (ACTUAL)
- **Last updated:** 2025-03-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00131235

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00131235, "Gestational Sulfadoxine-pyrimethamine and Azithromycin Treatment to Prevent Preterm Birth". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT00131235. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*